Literature DB >> 33407768

Characteristics and clinical outcomes of culture-negative and culture-positive septic shock: a single-center retrospective cohort study.

June-Sung Kim1, Youn-Jung Kim1, Won Young Kim2.   

Abstract

BACKGROUND: We evaluated the characteristics and outcomes of culture-negative versus culture-positive septic shock.
METHODS: We performed a retrospective observational study of data from a prospective registry from 2014 to 2018. A total of 2,499 adult patients with septic shock were enrolled. The primary outcome was 90-day mortality, and the secondary outcomes were the length of hospital stay, a requirement for mechanical ventilation or renal replacement therapy, and in-hospital mortality.
RESULTS: Of 1,718 patients with septic shock, 1,012 (58.9%) patients were culture-positive (blood 803, urine 302, sputum 102, others 204) and the median pathogen detection time was 9.5 h (aerobic 10.2 h and anaerobic 9.0 h). The most common site of culture-positive infection was the hepatobiliary tract (39.5%), while for the culture-negative it was the lower respiratory tract (38.2%). The culture-negative group had a lower mean body temperature (37.3 vs 37.7 ℃), lactate (2.5 vs. 3.2 mmol/L), C-reactive protein (11.1 vs 11.9 mg/dL), and sequential organ failure assessment score (7.0 vs. 8.0) than that of the culture-positive group. However, 90-day mortality between the groups was not significantly different (32.7 vs 32.2%, p = 0.83), and the other clinical outcomes also did not differ significantly. Moreover, a shorter culture detection time was correlated with a higher sequential organ failure assessment score but not with mortality.
CONCLUSION: Patients with septic shock are frequently culture-negative, especially in cases where the infection focus is in the lower respiratory tract. Although culture-negative was associated with a degree of organ dysfunction, it was not an independent predictor of death.

Entities:  

Keywords:  Culture; Mortality; Sepsis; Septic shock; Time to blood culture positivity

Mesh:

Year:  2021        PMID: 33407768      PMCID: PMC7787242          DOI: 10.1186/s13054-020-03421-4

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  29 in total

1.  Time to blood culture positivity: An independent predictor of infective endocarditis and mortality in patients with Staphylococcus aureus bacteraemia.

Authors:  S Siméon; V Le Moing; S Tubiana; X Duval; D Fournier; J-P Lavigne; M-L Erpelding; C-A Gustave; S Desage; C Chirouze; F Vandenesch; P Tattevin
Journal:  Clin Microbiol Infect       Date:  2018-07-21       Impact factor: 8.067

2.  Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort Study.

Authors:  Shravan Kethireddy; Beliz Bilgili; Amanda Sees; H Lester Kirchner; Uchenna R Ofoma; R Bruce Light; Yazdan Mirzanejad; Dennis Maki; Aseem Kumar; A Joseph Layon; Joseph E Parrillo; Anand Kumar
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

3.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

4.  A comparison of culture-positive and culture-negative health-care-associated pneumonia.

Authors:  Andrew J Labelle; Heather Arnold; Richard M Reichley; Scott T Micek; Marin H Kollef
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

5.  The impact of delayed biliary decompression and anti-microbial therapy in 260 patients with cholangitis-associated septic shock.

Authors:  C J Karvellas; J G Abraldes; S Zepeda-Gomez; D C Moffat; Y Mirzanejad; G Vazquez-Grande; E K Esfahani; A Kumar
Journal:  Aliment Pharmacol Ther       Date:  2016-08-10       Impact factor: 8.171

6.  Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes.

Authors:  Shipra Gupta; Ankit Sakhuja; Gagan Kumar; Eric McGrath; Rahul S Nanchal; Kianoush B Kashani
Journal:  Chest       Date:  2016-09-09       Impact factor: 9.410

7.  The role of bacterial culture by bronchoscopy in patients with lung cancer: a prospective study.

Authors:  Matthew Koslow; Gali Epstein Shochet; Alona Matveychuk; Lilach Israeli-Shani; Alexander Guber; David Shitrit
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 8.  Invasive candidiasis as a cause of sepsis in the critically ill patient.

Authors:  Julie Delaloye; Thierry Calandra
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882

9.  Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan.

Authors:  Toshikazu Abe; Hiroshi Ogura; Shigeki Kushimoto; Atsushi Shiraishi; Takehiro Sugiyama; Gautam A Deshpande; Masatoshi Uchida; Isao Nagata; Daizoh Saitoh; Seitaro Fujishima; Toshihiko Mayumi; Toru Hifumi; Yasukazu Shiino; Taka-Aki Nakada; Takehiko Tarui; Yasuhiro Otomo; Kohji Okamoto; Yutaka Umemura; Joji Kotani; Yuichiro Sakamoto; Junichi Sasaki; Shin-Ichiro Shiraishi; Kiyotsugu Takuma; Ryosuke Tsuruta; Akiyoshi Hagiwara; Kazuma Yamakawa; Tomohiko Masuno; Naoshi Takeyama; Norio Yamashita; Hiroto Ikeda; Masashi Ueyama; Satoshi Fujimi; Satoshi Gando
Journal:  J Intensive Care       Date:  2019-05-03

10.  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.

Authors:  Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2020-01-18       Impact factor: 202.731

View more
  4 in total

1.  The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock.

Authors:  June-Sung Kim; Jiyeon Ha; Youn-Jung Kim; Yousun Ko; Taeyong Park; Kyung Won Kim; Won Young Kim
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

2.  Comparison of culture-negative and culture-positive sepsis or septic shock: a systematic review and meta-analysis.

Authors:  Yuting Li; Jianxing Guo; Hongmei Yang; Hongxiang Li; Yangyang Shen; Dong Zhang
Journal:  Crit Care       Date:  2021-05-08       Impact factor: 9.097

3.  The Correlation Between the Types of Initial Bacterial Infection and Clinical Prognosis in Patients With Septic AKI.

Authors:  Tian Li; Jing Yuan Liu; Jing Feng Liu; Meili Duan; Ang Li
Journal:  Front Med (Lausanne)       Date:  2022-01-27

4.  Multidrug-resistant organisms: A significant cause of severe sepsis in pediatric intestinal and multi-visceral transplantation.

Authors:  Alicia M Alcamo; Mira K Trivedi; Carly Dulabon; Christopher M Horvat; Geoffrey J Bond; Joseph A Carcillo; Michael Green; Marian G Michaels; Rajesh K Aneja
Journal:  Am J Transplant       Date:  2021-07-28       Impact factor: 8.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.